<?xml version="1.0" encoding="UTF-8"?>

<document id="DDI-DrugBank.d288"> 
   <sentence id="DDI-DrugBank.d288.s0" text="In a Phase I trial using escalating doses of TAXOL (110-200 mg/m2) and cisplatin (50 or 75 mg/m2) given as sequential infusions, myelosuppression was more profound when TAXOL was given after cisplatin than with the alternate sequence (ie, TAXOL before cisplatin)." new_text="In@@a@@Phase@@I@@trial@@using@@escalating@@doses@@of@@TAXOL@@(110-200@@mg/m2)@@and@@cisplatin@@(50@@or@@75@@mg/m2)@@given@@as@@sequential@@infusions@@,@@myelosuppression@@was@@more@@profound@@when@@TAXOL@@was@@given@@after@@cisplatin@@than@@with@@the@@alternate@@sequence@@(ie@@,@@TAXOL@@before@@cisplatin@@)@@.@@"> 
      <entity id="DDI-DrugBank.d288.s0.e0" charOffset="45-49" type="brand" text="TAXOL" position="9"/>  
      <entity id="DDI-DrugBank.d288.s0.e1" charOffset="71-79" type="drug" text="cisplatin" position="13"/>  
      <entity id="DDI-DrugBank.d288.s0.e2" charOffset="169-173" type="brand" text="TAXOL" position="28"/>  
      <entity id="DDI-DrugBank.d288.s0.e3" charOffset="191-199" type="drug" text="cisplatin" position="32"/>  
      <entity id="DDI-DrugBank.d288.s0.e4" charOffset="239-243" type="brand" text="TAXOL" position="40"/>  
      <entity id="DDI-DrugBank.d288.s0.e5" charOffset="252-260" type="drug" text="cisplatin" position="42"/>  
      <pair id="DDI-DrugBank.d288.s0.p0" e1="DDI-DrugBank.d288.s0.e0" e2="DDI-DrugBank.d288.s0.e1" ddi="false" flags="True" e1_name="TAXOL" e2_name="cisplatin" e1_pos="9" e2_pos="13" path="9@@17@@13@@">TAXOL@@@@amod@@mg/m2)@@nn@@cisplatin</pair>  
      <pair id="DDI-DrugBank.d288.s0.p1" e1="DDI-DrugBank.d288.s0.e0" e2="DDI-DrugBank.d288.s0.e2" ddi="false" flags="True" e1_name="TAXOL" e2_name="TAXOL" e1_pos="9" e2_pos="28" path="9@@17@@7@@6@@5@@4@@26@@30@@28@@">TAXOL@@@@amod@@mg/m2)@@prep_of@@doses@@dobj@@escalating@@xcomp@@using@@partmod@@trial@@prep_in@@profound@@ccomp@@given@@nsubjpass@@TAXOL</pair>  
      <pair id="DDI-DrugBank.d288.s0.p2" e1="DDI-DrugBank.d288.s0.e0" e2="DDI-DrugBank.d288.s0.e3" ddi="false" flags="True" e1_name="TAXOL" e2_name="cisplatin" e1_pos="9" e2_pos="32" path="9@@17@@7@@6@@5@@4@@26@@30@@32@@">TAXOL@@@@amod@@mg/m2)@@prep_of@@doses@@dobj@@escalating@@xcomp@@using@@partmod@@trial@@prep_in@@profound@@ccomp@@given@@prep_after@@cisplatin</pair>  
      <pair id="DDI-DrugBank.d288.s0.p3" e1="DDI-DrugBank.d288.s0.e0" e2="DDI-DrugBank.d288.s0.e4" ddi="false" flags="True" e1_name="TAXOL" e2_name="TAXOL" e1_pos="9" e2_pos="40" path="9@@17@@7@@6@@5@@4@@26@@30@@38@@40@@">TAXOL@@@@amod@@mg/m2)@@prep_of@@doses@@dobj@@escalating@@xcomp@@using@@partmod@@trial@@prep_in@@profound@@ccomp@@given@@prep_with@@(ie@@appos@@TAXOL</pair>  
      <pair id="DDI-DrugBank.d288.s0.p4" e1="DDI-DrugBank.d288.s0.e0" e2="DDI-DrugBank.d288.s0.e5" ddi="false" flags="True" e1_name="TAXOL" e2_name="cisplatin" e1_pos="9" e2_pos="42" path="9@@17@@7@@6@@5@@4@@26@@30@@43@@42@@">TAXOL@@@@amod@@mg/m2)@@prep_of@@doses@@dobj@@escalating@@xcomp@@using@@partmod@@trial@@prep_in@@profound@@ccomp@@given@@prep_before@@)@@nn@@cisplatin</pair>  
      <pair id="DDI-DrugBank.d288.s0.p5" e1="DDI-DrugBank.d288.s0.e1" e2="DDI-DrugBank.d288.s0.e2" ddi="false" flags="True" e1_name="cisplatin" e2_name="TAXOL" e1_pos="13" e2_pos="28" path="13@@17@@7@@6@@5@@4@@26@@30@@28@@">cisplatin@@@@nn@@mg/m2)@@prep_of@@doses@@dobj@@escalating@@xcomp@@using@@partmod@@trial@@prep_in@@profound@@ccomp@@given@@nsubjpass@@TAXOL</pair>  
      <pair id="DDI-DrugBank.d288.s0.p6" e1="DDI-DrugBank.d288.s0.e1" e2="DDI-DrugBank.d288.s0.e3" ddi="false" flags="True" e1_name="cisplatin" e2_name="cisplatin" e1_pos="13" e2_pos="32" path="13@@17@@7@@6@@5@@4@@26@@30@@32@@">cisplatin@@@@nn@@mg/m2)@@prep_of@@doses@@dobj@@escalating@@xcomp@@using@@partmod@@trial@@prep_in@@profound@@ccomp@@given@@prep_after@@cisplatin</pair>  
      <pair id="DDI-DrugBank.d288.s0.p7" e1="DDI-DrugBank.d288.s0.e1" e2="DDI-DrugBank.d288.s0.e4" ddi="false" flags="True" e1_name="cisplatin" e2_name="TAXOL" e1_pos="13" e2_pos="40" path="13@@17@@7@@6@@5@@4@@26@@30@@38@@40@@">cisplatin@@@@nn@@mg/m2)@@prep_of@@doses@@dobj@@escalating@@xcomp@@using@@partmod@@trial@@prep_in@@profound@@ccomp@@given@@prep_with@@(ie@@appos@@TAXOL</pair>  
      <pair id="DDI-DrugBank.d288.s0.p8" e1="DDI-DrugBank.d288.s0.e1" e2="DDI-DrugBank.d288.s0.e5" ddi="false" flags="True" e1_name="cisplatin" e2_name="cisplatin" e1_pos="13" e2_pos="42" path="13@@17@@7@@6@@5@@4@@26@@30@@43@@42@@">cisplatin@@@@nn@@mg/m2)@@prep_of@@doses@@dobj@@escalating@@xcomp@@using@@partmod@@trial@@prep_in@@profound@@ccomp@@given@@prep_before@@)@@nn@@cisplatin</pair>  
      <pair id="DDI-DrugBank.d288.s0.p9" e1="DDI-DrugBank.d288.s0.e2" e2="DDI-DrugBank.d288.s0.e3" ddi="true" type="effect" flags="True" e1_name="TAXOL" e2_name="cisplatin" e1_pos="28" e2_pos="32" path="28@@30@@32@@">TAXOL@@@@nsubjpass@@given@@prep_after@@cisplatin</pair>  
      <pair id="DDI-DrugBank.d288.s0.p10" e1="DDI-DrugBank.d288.s0.e2" e2="DDI-DrugBank.d288.s0.e4" ddi="false" flags="True" e1_name="TAXOL" e2_name="TAXOL" e1_pos="28" e2_pos="40" path="28@@30@@38@@40@@">TAXOL@@@@nsubjpass@@given@@prep_with@@(ie@@appos@@TAXOL</pair>  
      <pair id="DDI-DrugBank.d288.s0.p11" e1="DDI-DrugBank.d288.s0.e2" e2="DDI-DrugBank.d288.s0.e5" ddi="false" flags="True" e1_name="TAXOL" e2_name="cisplatin" e1_pos="28" e2_pos="42" path="28@@30@@43@@42@@">TAXOL@@@@nsubjpass@@given@@prep_before@@)@@nn@@cisplatin</pair>  
      <pair id="DDI-DrugBank.d288.s0.p12" e1="DDI-DrugBank.d288.s0.e3" e2="DDI-DrugBank.d288.s0.e4" ddi="false" flags="True" e1_name="cisplatin" e2_name="TAXOL" e1_pos="32" e2_pos="40" path="32@@30@@38@@40@@">cisplatin@@@@prep_after@@given@@prep_with@@(ie@@appos@@TAXOL</pair>  
      <pair id="DDI-DrugBank.d288.s0.p13" e1="DDI-DrugBank.d288.s0.e3" e2="DDI-DrugBank.d288.s0.e5" ddi="false" flags="True" e1_name="cisplatin" e2_name="cisplatin" e1_pos="32" e2_pos="42" path="32@@30@@43@@42@@">cisplatin@@@@prep_after@@given@@prep_before@@)@@nn@@cisplatin</pair>  
      <pair id="DDI-DrugBank.d288.s0.p14" e1="DDI-DrugBank.d288.s0.e4" e2="DDI-DrugBank.d288.s0.e5" ddi="false" flags="True" e1_name="TAXOL" e2_name="cisplatin" e1_pos="40" e2_pos="42" path="40@@38@@30@@43@@42@@">TAXOL@@@@appos@@(ie@@prep_with@@given@@prep_before@@)@@nn@@cisplatin</pair> 
   </sentence>  
   <sentence id="DDI-DrugBank.d288.s1" text="Pharmacokinetic data from these patients demonstrated a decrease in paclitaxel clearance of approximately 33% when TAXOL was administered following cisplatin." new_text="Pharmacokinetic@@data@@from@@these@@patients@@demonstrated@@a@@decrease@@in@@paclitaxel@@clearance@@of@@approximately@@33%@@when@@TAXOL@@was@@administered@@following@@cisplatin@@.@@"> 
      <entity id="DDI-DrugBank.d288.s1.e0" charOffset="68-77" type="drug" text="paclitaxel" position="9"/>  
      <entity id="DDI-DrugBank.d288.s1.e1" charOffset="115-119" type="brand" text="TAXOL" position="15"/>  
      <entity id="DDI-DrugBank.d288.s1.e2" charOffset="148-156" type="drug" text="cisplatin" position="19"/>  
      <pair id="DDI-DrugBank.d288.s1.p0" e1="DDI-DrugBank.d288.s1.e0" e2="DDI-DrugBank.d288.s1.e1" ddi="false" flags="True" e1_name="paclitaxel" e2_name="TAXOL" e1_pos="9" e2_pos="15" path="9@@10@@5@@17@@15@@">paclitaxel@@@@amod@@clearance@@prep_in@@demonstrated@@advcl@@administered@@nsubjpass@@TAXOL</pair>  
      <pair id="DDI-DrugBank.d288.s1.p1" e1="DDI-DrugBank.d288.s1.e0" e2="DDI-DrugBank.d288.s1.e2" ddi="false" flags="True" e1_name="paclitaxel" e2_name="cisplatin" e1_pos="9" e2_pos="19" path="9@@10@@5@@17@@19@@">paclitaxel@@@@amod@@clearance@@prep_in@@demonstrated@@advcl@@administered@@prep_following@@cisplatin</pair>  
      <pair id="DDI-DrugBank.d288.s1.p2" e1="DDI-DrugBank.d288.s1.e1" e2="DDI-DrugBank.d288.s1.e2" ddi="true" type="mechanism" flags="True" e1_name="TAXOL" e2_name="cisplatin" e1_pos="15" e2_pos="19" path="15@@17@@19@@">TAXOL@@@@nsubjpass@@administered@@prep_following@@cisplatin</pair> 
   </sentence>  
   <sentence id="DDI-DrugBank.d288.s2" text="The metabolism of TAXOL is catalyzed by cytochrome P450 isoen-zymes CYP2C8 and CYP3A4." new_text="The@@metabolism@@of@@TAXOL@@is@@catalyzed@@by@@cytochrome@@P450@@isoen-zymes@@CYP2C8@@and@@CYP3A4@@.@@"> 
      <entity id="DDI-DrugBank.d288.s2.e0" charOffset="18-22" type="brand" text="TAXOL" position="3"/> 
   </sentence>  
   <sentence id="DDI-DrugBank.d288.s3" text="In the absence of formal clinical drug interaction studies, caution should be exercised when administering TAXOL concomitantly with known substrates or inhibitors of the cytochrome P450 isoenzymes CYP2C8 and CYP3A4." new_text="In@@the@@absence@@of@@formal@@clinical@@drug@@interaction@@studies@@,@@caution@@should@@be@@exercised@@when@@administering@@TAXOL@@concomitantly@@with@@known@@substrates@@or@@inhibitors@@of@@the@@cytochrome@@P450@@isoenzymes@@CYP2C8@@and@@CYP3A4@@.@@"> 
      <entity id="DDI-DrugBank.d288.s3.e0" charOffset="107-111" type="brand" text="TAXOL" position="16"/> 
   </sentence>  
   <sentence id="DDI-DrugBank.d288.s4" text="Potential interactions between TAXOL, a substrate of CYP3A4, and protease inhibitors (ritonavir, saquinavir, indinavir, and nelfinavir), which are substrates and/or inhibitors of CYP3A4, have not been evaluated in clinical trials." new_text="Potential@@interactions@@between@@TAXOL@@,@@a@@substrate@@of@@CYP3A4@@,@@and@@protease inhibitors@@(@@ritonavir@@,@@saquinavir@@,@@indinavir@@,@@and@@nelfinavir@@)@@,@@which@@are@@substrates@@and/or@@inhibitors@@of@@CYP3A4@@,@@have@@not@@been@@evaluated@@in@@clinical@@trials@@.@@"> 
      <entity id="DDI-DrugBank.d288.s4.e0" charOffset="31-35" type="brand" text="TAXOL" position="3"/>  
      <entity id="DDI-DrugBank.d288.s4.e1" charOffset="65-83" type="group" text="protease inhibitors" position="11"/>  
      <entity id="DDI-DrugBank.d288.s4.e2" charOffset="86-94" type="drug" text="ritonavir" position="13"/>  
      <entity id="DDI-DrugBank.d288.s4.e3" charOffset="97-106" type="drug" text="saquinavir" position="15"/>  
      <entity id="DDI-DrugBank.d288.s4.e4" charOffset="109-117" type="drug" text="indinavir" position="17"/>  
      <entity id="DDI-DrugBank.d288.s4.e5" charOffset="124-133" type="drug" text="nelfinavir" position="20"/>  
      <pair id="DDI-DrugBank.d288.s4.p0" e1="DDI-DrugBank.d288.s4.e0" e2="DDI-DrugBank.d288.s4.e1" ddi="false" flags="True" e1_name="TAXOL" e2_name="protease inhibitors" e1_pos="3" e2_pos="11" path="3@@13@@11@@">TAXOL@@@@conj_and@@ritonavir@@amod@@protease inhibitors</pair>  
      <pair id="DDI-DrugBank.d288.s4.p1" e1="DDI-DrugBank.d288.s4.e0" e2="DDI-DrugBank.d288.s4.e2" ddi="false" flags="True" e1_name="TAXOL" e2_name="ritonavir" e1_pos="3" e2_pos="13" path="3@@13@@">TAXOL@@@@conj_and@@ritonavir</pair>  
      <pair id="DDI-DrugBank.d288.s4.p2" e1="DDI-DrugBank.d288.s4.e0" e2="DDI-DrugBank.d288.s4.e3" ddi="false" flags="True" e1_name="TAXOL" e2_name="saquinavir" e1_pos="3" e2_pos="15" path="3@@15@@">TAXOL@@@@conj_and@@saquinavir</pair>  
      <pair id="DDI-DrugBank.d288.s4.p3" e1="DDI-DrugBank.d288.s4.e0" e2="DDI-DrugBank.d288.s4.e4" ddi="false" flags="True" e1_name="TAXOL" e2_name="indinavir" e1_pos="3" e2_pos="17" path="3@@17@@">TAXOL@@@@conj_and@@indinavir</pair>  
      <pair id="DDI-DrugBank.d288.s4.p4" e1="DDI-DrugBank.d288.s4.e0" e2="DDI-DrugBank.d288.s4.e5" ddi="false" flags="True" e1_name="TAXOL" e2_name="nelfinavir" e1_pos="3" e2_pos="20" path="3@@21@@20@@">TAXOL@@@@conj_and@@)@@nn@@nelfinavir</pair>  
      <pair id="DDI-DrugBank.d288.s4.p5" e1="DDI-DrugBank.d288.s4.e1" e2="DDI-DrugBank.d288.s4.e2" ddi="false" flags="True" e1_name="protease inhibitors" e2_name="ritonavir" e1_pos="11" e2_pos="13" path="11@@13@@">protease inhibitors@@@@amod@@ritonavir</pair>  
      <pair id="DDI-DrugBank.d288.s4.p6" e1="DDI-DrugBank.d288.s4.e1" e2="DDI-DrugBank.d288.s4.e3" ddi="false" flags="True" e1_name="protease inhibitors" e2_name="saquinavir" e1_pos="11" e2_pos="15" path="11@@13@@1@@15@@">protease inhibitors@@@@amod@@ritonavir@@prep_between@@interactions@@prep_between@@saquinavir</pair>  
      <pair id="DDI-DrugBank.d288.s4.p7" e1="DDI-DrugBank.d288.s4.e1" e2="DDI-DrugBank.d288.s4.e4" ddi="false" flags="True" e1_name="protease inhibitors" e2_name="indinavir" e1_pos="11" e2_pos="17" path="11@@13@@1@@17@@">protease inhibitors@@@@amod@@ritonavir@@prep_between@@interactions@@prep_between@@indinavir</pair>  
      <pair id="DDI-DrugBank.d288.s4.p8" e1="DDI-DrugBank.d288.s4.e1" e2="DDI-DrugBank.d288.s4.e5" ddi="false" flags="True" e1_name="protease inhibitors" e2_name="nelfinavir" e1_pos="11" e2_pos="20" path="11@@13@@1@@21@@20@@">protease inhibitors@@@@amod@@ritonavir@@prep_between@@interactions@@prep_between@@)@@nn@@nelfinavir</pair>  
      <pair id="DDI-DrugBank.d288.s4.p9" e1="DDI-DrugBank.d288.s4.e2" e2="DDI-DrugBank.d288.s4.e3" ddi="false" flags="True" e1_name="ritonavir" e2_name="saquinavir" e1_pos="13" e2_pos="15" path="13@@1@@15@@">ritonavir@@@@prep_between@@interactions@@prep_between@@saquinavir</pair>  
      <pair id="DDI-DrugBank.d288.s4.p10" e1="DDI-DrugBank.d288.s4.e2" e2="DDI-DrugBank.d288.s4.e4" ddi="false" flags="True" e1_name="ritonavir" e2_name="indinavir" e1_pos="13" e2_pos="17" path="13@@1@@17@@">ritonavir@@@@prep_between@@interactions@@prep_between@@indinavir</pair>  
      <pair id="DDI-DrugBank.d288.s4.p11" e1="DDI-DrugBank.d288.s4.e2" e2="DDI-DrugBank.d288.s4.e5" ddi="false" flags="True" e1_name="ritonavir" e2_name="nelfinavir" e1_pos="13" e2_pos="20" path="13@@1@@21@@20@@">ritonavir@@@@prep_between@@interactions@@prep_between@@)@@nn@@nelfinavir</pair>  
      <pair id="DDI-DrugBank.d288.s4.p12" e1="DDI-DrugBank.d288.s4.e3" e2="DDI-DrugBank.d288.s4.e4" ddi="false" flags="True" e1_name="saquinavir" e2_name="indinavir" e1_pos="15" e2_pos="17" path="15@@1@@17@@">saquinavir@@@@prep_between@@interactions@@prep_between@@indinavir</pair>  
      <pair id="DDI-DrugBank.d288.s4.p13" e1="DDI-DrugBank.d288.s4.e3" e2="DDI-DrugBank.d288.s4.e5" ddi="false" flags="True" e1_name="saquinavir" e2_name="nelfinavir" e1_pos="15" e2_pos="20" path="15@@1@@21@@20@@">saquinavir@@@@prep_between@@interactions@@prep_between@@)@@nn@@nelfinavir</pair>  
      <pair id="DDI-DrugBank.d288.s4.p14" e1="DDI-DrugBank.d288.s4.e4" e2="DDI-DrugBank.d288.s4.e5" ddi="false" flags="True" e1_name="indinavir" e2_name="nelfinavir" e1_pos="17" e2_pos="20" path="17@@1@@21@@20@@">indinavir@@@@prep_between@@interactions@@prep_between@@)@@nn@@nelfinavir</pair> 
   </sentence>  
   <sentence id="DDI-DrugBank.d288.s5" text="Reports in the literature suggest that plasma levels of doxorubicin (and its active metabolite doxorubicinol) may be increased when paclitaxel and doxorubicin are used in combination." new_text="Reports@@in@@the@@literature@@suggest@@that@@plasma@@levels@@of@@doxorubicin@@(and@@its@@active@@metabolite@@doxorubicinol@@)@@may@@be@@increased@@when@@paclitaxel@@and@@doxorubicin@@are@@used@@in@@combination@@.@@"> 
      <entity id="DDI-DrugBank.d288.s5.e0" charOffset="56-66" type="drug" text="doxorubicin" position="9"/>  
      <entity id="DDI-DrugBank.d288.s5.e1" charOffset="95-107" type="drug_n" text="doxorubicinol" position="14"/>  
      <entity id="DDI-DrugBank.d288.s5.e2" charOffset="132-141" type="drug" text="paclitaxel" position="20"/>  
      <entity id="DDI-DrugBank.d288.s5.e3" charOffset="147-157" type="drug" text="doxorubicin" position="22"/>  
      <pair id="DDI-DrugBank.d288.s5.p0" e1="DDI-DrugBank.d288.s5.e0" e2="DDI-DrugBank.d288.s5.e1" ddi="false" flags="True" e1_name="doxorubicin" e2_name="doxorubicinol" e1_pos="9" e2_pos="14" path="9@@7@@10@@18@@15@@14@@">doxorubicin@@@@prep_of@@levels@@nsubj@@(and@@ccomp@@increased@@nsubjpass@@)@@nn@@doxorubicinol</pair>  
      <pair id="DDI-DrugBank.d288.s5.p1" e1="DDI-DrugBank.d288.s5.e0" e2="DDI-DrugBank.d288.s5.e2" ddi="false" flags="True" e1_name="doxorubicin" e2_name="paclitaxel" e1_pos="9" e2_pos="20" path="9@@7@@10@@18@@24@@20@@">doxorubicin@@@@prep_of@@levels@@nsubj@@(and@@ccomp@@increased@@advcl@@used@@nsubjpass@@paclitaxel</pair>  
      <pair id="DDI-DrugBank.d288.s5.p2" e1="DDI-DrugBank.d288.s5.e0" e2="DDI-DrugBank.d288.s5.e3" ddi="false" flags="True" e1_name="doxorubicin" e2_name="doxorubicin" e1_pos="9" e2_pos="22" path="9@@7@@10@@18@@24@@22@@">doxorubicin@@@@prep_of@@levels@@nsubj@@(and@@ccomp@@increased@@advcl@@used@@nsubjpass@@doxorubicin</pair>  
      <pair id="DDI-DrugBank.d288.s5.p3" e1="DDI-DrugBank.d288.s5.e1" e2="DDI-DrugBank.d288.s5.e2" ddi="false" flags="True" e1_name="doxorubicinol" e2_name="paclitaxel" e1_pos="14" e2_pos="20" path="14@@15@@18@@24@@20@@">doxorubicinol@@@@nn@@)@@nsubjpass@@increased@@advcl@@used@@nsubjpass@@paclitaxel</pair>  
      <pair id="DDI-DrugBank.d288.s5.p4" e1="DDI-DrugBank.d288.s5.e1" e2="DDI-DrugBank.d288.s5.e3" ddi="false" flags="True" e1_name="doxorubicinol" e2_name="doxorubicin" e1_pos="14" e2_pos="22" path="14@@15@@18@@24@@22@@">doxorubicinol@@@@nn@@)@@nsubjpass@@increased@@advcl@@used@@nsubjpass@@doxorubicin</pair>  
      <pair id="DDI-DrugBank.d288.s5.p5" e1="DDI-DrugBank.d288.s5.e2" e2="DDI-DrugBank.d288.s5.e3" ddi="true" type="mechanism" flags="True" e1_name="paclitaxel" e2_name="doxorubicin" e1_pos="20" e2_pos="22" path="20@@22@@">paclitaxel@@@@conj_and@@doxorubicin</pair> 
   </sentence>  
   <sentence id="DDI-DrugBank.d288.s6" text="Hematology: TAXOL therapy should not be administered to patients with baseline neutrophil counts of less than 1,500 cells/mm3." new_text="Hematology@@:@@TAXOL@@therapy@@should@@not@@be@@administered@@to@@patients@@with@@baseline@@neutrophil@@counts@@of@@less@@than@@1,500@@cells/mm3@@.@@"> 
      <entity id="DDI-DrugBank.d288.s6.e0" charOffset="12-16" type="brand" text="TAXOL" position="2"/> 
   </sentence>  
   <sentence id="DDI-DrugBank.d288.s7" text="In order to monitor the occurrence of myelotoxicity, it is recommended that frequent peripheral blood cell counts be performed on all patients receiving TAXOL." new_text="In@@order@@to@@monitor@@the@@occurrence@@of@@myelotoxicity@@,@@it@@is@@recommended@@that@@frequent@@peripheral@@blood@@cell@@counts@@be@@performed@@on@@all@@patients@@receiving@@TAXOL@@.@@"> 
      <entity id="DDI-DrugBank.d288.s7.e0" charOffset="153-157" type="brand" text="TAXOL" position="24"/> 
   </sentence>  
   <sentence id="DDI-DrugBank.d288.s8" text="Patients should not be re-treated with subsequent cycles of TAXOL until neutrophils recover to a level  1500 cells/mm3 and platelets recover to a level  100,000 cells/mm3." new_text="Patients@@should@@not@@be@@re-treated@@with@@subsequent@@cycles@@of@@TAXOL@@until@@neutrophils@@recover@@to@@a@@level@@@@1500@@cells/mm3@@and@@platelets@@recover@@to@@a@@level@@@@100,000@@cells/mm3@@.@@"> 
      <entity id="DDI-DrugBank.d288.s8.e0" charOffset="60-64" type="brand" text="TAXOL" position="9"/> 
   </sentence>  
   <sentence id="DDI-DrugBank.d288.s9" text="In the case of severe neutropenia ( 500 cells/mm3 for seven days or more) during a course of TAXOL therapy, a 20% reduction in dose for subsequent courses of therapy is recommended." new_text="In@@the@@case@@of@@severe@@neutropenia@@(@@500@@cells/mm3@@for@@seven@@days@@or@@more)@@during@@a@@course@@of@@TAXOL@@therapy@@,@@a@@20%@@reduction@@in@@dose@@for@@subsequent@@courses@@of@@therapy@@is@@recommended@@.@@"> 
      <entity id="DDI-DrugBank.d288.s9.e0" charOffset="93-97" type="brand" text="TAXOL" position="18"/> 
   </sentence>  
   <sentence id="DDI-DrugBank.d288.s10" text="For patients with advanced HIV disease and poor-risk AIDS-related Kaposi s sarcoma, TAXOL, at the recommended dose for this disease, can be initiated and repeated if the neutrophil count is at least 1000 cells/mm3." new_text="For@@patients@@with@@advanced@@HIV@@disease@@and@@poor-risk@@AIDS-related@@Kaposi@@s@@sarcoma@@,@@TAXOL@@,@@at@@the@@recommended@@dose@@for@@this@@disease@@,@@can@@be@@initiated@@and@@repeated@@if@@the@@neutrophil@@count@@is@@at@@least@@1000@@cells/mm3@@.@@"> 
      <entity id="DDI-DrugBank.d288.s10.e0" charOffset="84-88" type="brand" text="TAXOL" position="13"/> 
   </sentence>  
   <sentence id="DDI-DrugBank.d288.s11" text="Hypersensitivity Reactions: Patients with a history of severe hypersensitivity reactions to products containing Cremophor  EL (eg, cyclosporin for injection concentrate and teniposide for injection concentrate) should not be treated with TAXOL." new_text="Hypersensitivity@@Reactions@@:@@Patients@@with@@a@@history@@of@@severe@@hypersensitivity@@reactions@@to@@products@@containing@@Cremophor@@@@EL@@(eg@@,@@cyclosporin@@for@@injection@@concentrate@@and@@teniposide@@for@@injection@@concentrate)@@should@@not@@be@@treated@@with@@TAXOL@@.@@"> 
      <entity id="DDI-DrugBank.d288.s11.e0" charOffset="131-141" type="drug" text="cyclosporin" position="19"/>  
      <entity id="DDI-DrugBank.d288.s11.e1" charOffset="173-182" type="drug" text="teniposide" position="24"/>  
      <entity id="DDI-DrugBank.d288.s11.e2" charOffset="238-242" type="brand" text="TAXOL" position="33"/>  
      <pair id="DDI-DrugBank.d288.s11.p0" e1="DDI-DrugBank.d288.s11.e0" e2="DDI-DrugBank.d288.s11.e1" ddi="false" flags="True" e1_name="cyclosporin" e2_name="teniposide" e1_pos="19" e2_pos="24" path="19@@24@@">cyclosporin@@@@prep_for@@teniposide</pair>  
      <pair id="DDI-DrugBank.d288.s11.p1" e1="DDI-DrugBank.d288.s11.e0" e2="DDI-DrugBank.d288.s11.e2" ddi="true" type="advise" flags="True" e1_name="cyclosporin" e2_name="TAXOL" e1_pos="19" e2_pos="33" path="19@@17@@13@@31@@33@@">cyclosporin@@@@appos@@(eg@@dobj@@containing@@advcl@@treated@@prep_with@@TAXOL</pair>  
      <pair id="DDI-DrugBank.d288.s11.p2" e1="DDI-DrugBank.d288.s11.e1" e2="DDI-DrugBank.d288.s11.e2" ddi="true" type="advise" flags="True" e1_name="teniposide" e2_name="TAXOL" e1_pos="24" e2_pos="33" path="24@@19@@17@@13@@31@@33@@">teniposide@@@@prep_for@@cyclosporin@@appos@@(eg@@dobj@@containing@@advcl@@treated@@prep_with@@TAXOL</pair> 
   </sentence>  
   <sentence id="DDI-DrugBank.d288.s12" text="In order to avoid the occurrence of severe hypersensitivity reactions, all patients treated with TAXOL should be premedicated with corticosteroids (such as dexamethasone), diphen-hydramine and H2 antagonists (such as cimetidine or ranitidine)." new_text="In@@order@@to@@avoid@@the@@occurrence@@of@@severe@@hypersensitivity@@reactions@@,@@all@@patients@@treated@@with@@TAXOL@@should@@be@@premedicated@@with@@corticosteroids@@(such@@as@@dexamethasone@@)@@,@@diphen-hydramine@@and@@H2 antagonists@@(such@@as@@cimetidine@@or@@ranitidine@@)@@.@@"> 
      <entity id="DDI-DrugBank.d288.s12.e0" charOffset="97-101" type="brand" text="TAXOL" position="15"/>  
      <entity id="DDI-DrugBank.d288.s12.e1" charOffset="131-145" type="group" text="corticosteroids" position="20"/>  
      <entity id="DDI-DrugBank.d288.s12.e2" charOffset="156-168" type="drug" text="dexamethasone" position="23"/>  
      <entity id="DDI-DrugBank.d288.s12.e3" charOffset="193-206" type="group" text="H2 antagonists" position="28"/>  
      <entity id="DDI-DrugBank.d288.s12.e4" charOffset="217-226" type="drug" text="cimetidine" position="31"/>  
      <entity id="DDI-DrugBank.d288.s12.e5" charOffset="231-240" type="drug" text="ranitidine" position="33"/>  
      <pair id="DDI-DrugBank.d288.s12.p0" e1="DDI-DrugBank.d288.s12.e0" e2="DDI-DrugBank.d288.s12.e1" ddi="false" flags="True" e1_name="TAXOL" e2_name="corticosteroids" e1_pos="15" e2_pos="20" path="15@@13@@12@@18@@21@@20@@">TAXOL@@@@prep_with@@treated@@partmod@@patients@@nsubjpass@@premedicated@@prep_with@@(such@@amod@@corticosteroids</pair>  
      <pair id="DDI-DrugBank.d288.s12.p1" e1="DDI-DrugBank.d288.s12.e0" e2="DDI-DrugBank.d288.s12.e2" ddi="false" flags="True" e1_name="TAXOL" e2_name="dexamethasone" e1_pos="15" e2_pos="23" path="15@@13@@12@@18@@29@@23@@">TAXOL@@@@prep_with@@treated@@partmod@@patients@@nsubjpass@@premedicated@@prep_as@@(such@@amod@@dexamethasone</pair>  
      <pair id="DDI-DrugBank.d288.s12.p2" e1="DDI-DrugBank.d288.s12.e0" e2="DDI-DrugBank.d288.s12.e3" ddi="false" flags="True" e1_name="TAXOL" e2_name="H2 antagonists" e1_pos="15" e2_pos="28" path="15@@13@@12@@18@@29@@28@@">TAXOL@@@@prep_with@@treated@@partmod@@patients@@nsubjpass@@premedicated@@prep_as@@(such@@amod@@H2 antagonists</pair>  
      <pair id="DDI-DrugBank.d288.s12.p3" e1="DDI-DrugBank.d288.s12.e0" e2="DDI-DrugBank.d288.s12.e4" ddi="false" flags="True" e1_name="TAXOL" e2_name="cimetidine" e1_pos="15" e2_pos="31" path="15@@13@@12@@18@@29@@34@@31@@">TAXOL@@@@prep_with@@treated@@partmod@@patients@@nsubjpass@@premedicated@@prep_as@@(such@@prep_as@@)@@nn@@cimetidine</pair>  
      <pair id="DDI-DrugBank.d288.s12.p4" e1="DDI-DrugBank.d288.s12.e0" e2="DDI-DrugBank.d288.s12.e5" ddi="false" flags="True" e1_name="TAXOL" e2_name="ranitidine" e1_pos="15" e2_pos="33" path="15@@13@@12@@18@@29@@34@@33@@">TAXOL@@@@prep_with@@treated@@partmod@@patients@@nsubjpass@@premedicated@@prep_as@@(such@@prep_as@@)@@nn@@ranitidine</pair>  
      <pair id="DDI-DrugBank.d288.s12.p5" e1="DDI-DrugBank.d288.s12.e1" e2="DDI-DrugBank.d288.s12.e2" ddi="false" flags="True" e1_name="corticosteroids" e2_name="dexamethasone" e1_pos="20" e2_pos="23" path="20@@21@@18@@29@@23@@">corticosteroids@@@@amod@@(such@@prep_with@@premedicated@@prep_as@@(such@@amod@@dexamethasone</pair>  
      <pair id="DDI-DrugBank.d288.s12.p6" e1="DDI-DrugBank.d288.s12.e1" e2="DDI-DrugBank.d288.s12.e3" ddi="false" flags="True" e1_name="corticosteroids" e2_name="H2 antagonists" e1_pos="20" e2_pos="28" path="20@@21@@18@@29@@28@@">corticosteroids@@@@amod@@(such@@prep_with@@premedicated@@prep_as@@(such@@amod@@H2 antagonists</pair>  
      <pair id="DDI-DrugBank.d288.s12.p7" e1="DDI-DrugBank.d288.s12.e1" e2="DDI-DrugBank.d288.s12.e4" ddi="false" flags="True" e1_name="corticosteroids" e2_name="cimetidine" e1_pos="20" e2_pos="31" path="20@@21@@18@@29@@34@@31@@">corticosteroids@@@@amod@@(such@@prep_with@@premedicated@@prep_as@@(such@@prep_as@@)@@nn@@cimetidine</pair>  
      <pair id="DDI-DrugBank.d288.s12.p8" e1="DDI-DrugBank.d288.s12.e1" e2="DDI-DrugBank.d288.s12.e5" ddi="false" flags="True" e1_name="corticosteroids" e2_name="ranitidine" e1_pos="20" e2_pos="33" path="20@@21@@18@@29@@34@@33@@">corticosteroids@@@@amod@@(such@@prep_with@@premedicated@@prep_as@@(such@@prep_as@@)@@nn@@ranitidine</pair>  
      <pair id="DDI-DrugBank.d288.s12.p9" e1="DDI-DrugBank.d288.s12.e2" e2="DDI-DrugBank.d288.s12.e3" ddi="false" flags="True" e1_name="dexamethasone" e2_name="H2 antagonists" e1_pos="23" e2_pos="28" path="23@@29@@28@@">dexamethasone@@@@amod@@(such@@amod@@H2 antagonists</pair>  
      <pair id="DDI-DrugBank.d288.s12.p10" e1="DDI-DrugBank.d288.s12.e2" e2="DDI-DrugBank.d288.s12.e4" ddi="false" flags="True" e1_name="dexamethasone" e2_name="cimetidine" e1_pos="23" e2_pos="31" path="23@@29@@34@@31@@">dexamethasone@@@@amod@@(such@@prep_as@@)@@nn@@cimetidine</pair>  
      <pair id="DDI-DrugBank.d288.s12.p11" e1="DDI-DrugBank.d288.s12.e2" e2="DDI-DrugBank.d288.s12.e5" ddi="false" flags="True" e1_name="dexamethasone" e2_name="ranitidine" e1_pos="23" e2_pos="33" path="23@@29@@34@@33@@">dexamethasone@@@@amod@@(such@@prep_as@@)@@nn@@ranitidine</pair>  
      <pair id="DDI-DrugBank.d288.s12.p12" e1="DDI-DrugBank.d288.s12.e3" e2="DDI-DrugBank.d288.s12.e4" ddi="false" flags="True" e1_name="H2 antagonists" e2_name="cimetidine" e1_pos="28" e2_pos="31" path="28@@29@@34@@31@@">H2 antagonists@@@@amod@@(such@@prep_as@@)@@nn@@cimetidine</pair>  
      <pair id="DDI-DrugBank.d288.s12.p13" e1="DDI-DrugBank.d288.s12.e3" e2="DDI-DrugBank.d288.s12.e5" ddi="false" flags="True" e1_name="H2 antagonists" e2_name="ranitidine" e1_pos="28" e2_pos="33" path="28@@29@@34@@33@@">H2 antagonists@@@@amod@@(such@@prep_as@@)@@nn@@ranitidine</pair>  
      <pair id="DDI-DrugBank.d288.s12.p14" e1="DDI-DrugBank.d288.s12.e4" e2="DDI-DrugBank.d288.s12.e5" ddi="false" flags="True" e1_name="cimetidine" e2_name="ranitidine" e1_pos="31" e2_pos="33" path="31@@33@@">cimetidine@@@@conj_or@@ranitidine</pair> 
   </sentence>  
   <sentence id="DDI-DrugBank.d288.s13" text="Minor symptoms such as flushing, skin reactions, dyspnea, hypotension, or tachycardia do not require interruption of therapy." new_text="Minor@@symptoms@@such@@as@@flushing@@,@@skin@@reactions@@,@@dyspnea@@,@@hypotension@@,@@or@@tachycardia@@do@@not@@require@@interruption@@of@@therapy@@.@@"/>  
   <sentence id="DDI-DrugBank.d288.s14" text="However, severe reactions, such as hypotension requiring treatment, dyspnea requiring bronchodilators, angioedema, or generalized urticaria require immediate discontinuation of TAXOL and aggressive symptomatic therapy." new_text="However@@,@@severe@@reactions@@,@@such@@as@@hypotension@@requiring@@treatment@@,@@dyspnea@@requiring@@bronchodilators@@,@@angioedema@@,@@or@@generalized@@urticaria@@require@@immediate@@discontinuation@@of@@TAXOL@@and@@aggressive@@symptomatic@@therapy@@.@@"> 
      <entity id="DDI-DrugBank.d288.s14.e0" charOffset="86-100" type="group" text="bronchodilators" position="13"/>  
      <entity id="DDI-DrugBank.d288.s14.e1" charOffset="177-181" type="brand" text="TAXOL" position="24"/>  
      <pair id="DDI-DrugBank.d288.s14.p0" e1="DDI-DrugBank.d288.s14.e0" e2="DDI-DrugBank.d288.s14.e1" ddi="false" flags="True" e1_name="bronchodilators" e2_name="TAXOL" e1_pos="13" e2_pos="24" path="13@@12@@11@@3@@20@@22@@24@@">bronchodilators@@@@dobj@@requiring@@partmod@@dyspnea@@appos@@reactions@@nsubj@@require@@dobj@@discontinuation@@prep_of@@TAXOL</pair> 
   </sentence>  
   <sentence id="DDI-DrugBank.d288.s15" text="Patients who have developed severe hypersensitivity reactions should not be rechallenged with TAXOL." new_text="Patients@@who@@have@@developed@@severe@@hypersensitivity@@reactions@@should@@not@@be@@rechallenged@@with@@TAXOL@@.@@"> 
      <entity id="DDI-DrugBank.d288.s15.e0" charOffset="94-98" type="brand" text="TAXOL" position="12"/> 
   </sentence>  
   <sentence id="DDI-DrugBank.d288.s16" text="Cardiovascular: Hypotension, bradycardia, and hypertension have been observed during administration of TAXOL, but generally do not require treatment." new_text="Cardiovascular@@:@@Hypotension@@,@@bradycardia@@,@@and@@hypertension@@have@@been@@observed@@during@@administration@@of@@TAXOL@@,@@but@@generally@@do@@not@@require@@treatment@@.@@"> 
      <entity id="DDI-DrugBank.d288.s16.e0" charOffset="103-107" type="brand" text="TAXOL" position="14"/> 
   </sentence>  
   <sentence id="DDI-DrugBank.d288.s17" text="Occasionally TAXOL infusions must be interrupted or discontinued because of initial or recurrent hypertension." new_text="Occasionally@@TAXOL@@infusions@@must@@be@@interrupted@@or@@discontinued@@because@@of@@initial@@or@@recurrent@@hypertension@@.@@"> 
      <entity id="DDI-DrugBank.d288.s17.e0" charOffset="13-17" type="brand" text="TAXOL" position="1"/> 
   </sentence>  
   <sentence id="DDI-DrugBank.d288.s18" text="Frequent vital sign monitoring, particularly during the first hour of TAXOL infusion, is recommended." new_text="Frequent@@vital@@sign@@monitoring@@,@@particularly@@during@@the@@first@@hour@@of@@TAXOL@@infusion@@,@@is@@recommended@@.@@"> 
      <entity id="DDI-DrugBank.d288.s18.e0" charOffset="70-74" type="brand" text="TAXOL" position="11"/> 
   </sentence>  
   <sentence id="DDI-DrugBank.d288.s19" text="Continuous cardiac monitoring is not required except for patients with serious conduction abnormalities." new_text="Continuous@@cardiac@@monitoring@@is@@not@@required@@except@@for@@patients@@with@@serious@@conduction@@abnormalities@@.@@"/>  
   <sentence id="DDI-DrugBank.d288.s20" text="Nervous System: Although the occurrence of peripheral neuropathy is frequent, the development of severe symptomatology is unusual and requires a dose reduction of 20% for all subsequentcourses of TAXOL." new_text="Nervous@@System@@:@@Although@@the@@occurrence@@of@@peripheral@@neuropathy@@is@@frequent@@,@@the@@development@@of@@severe@@symptomatology@@is@@unusual@@and@@requires@@a@@dose@@reduction@@of@@20%@@for@@all@@subsequentcourses@@of@@TAXOL@@.@@"> 
      <entity id="DDI-DrugBank.d288.s20.e0" charOffset="196-200" type="brand" text="TAXOL" position="30"/> 
   </sentence>  
   <sentence id="DDI-DrugBank.d288.s21" text="TAXOL contains dehydrated alcohol USP, 396 mg/mL;" new_text="TAXOL@@contains@@dehydrated@@alcohol@@USP@@,@@396@@mg/mL;@@"> 
      <entity id="DDI-DrugBank.d288.s21.e0" charOffset="0-4" type="brand" text="TAXOL" position="0"/> 
   </sentence>  
   <sentence id="DDI-DrugBank.d288.s22" text="consideration should be given to possible CNS and other effects of alcohol." new_text="consideration@@should@@be@@given@@to@@possible@@CNS@@and@@other@@effects@@of@@alcohol@@.@@"> 
      <entity id="DDI-DrugBank.d288.s22.e0" charOffset="67-73" type="drug" text="alcohol" position="11"/> 
   </sentence>  
   <sentence id="DDI-DrugBank.d288.s23" text="Hepatic: There is limited evidence that the myelotoxicity of TAXOL may be exacerbated in patients with serum total bilirubin  2 times ULN." new_text="Hepatic@@:@@There@@is@@limited@@evidence@@that@@the@@myelotoxicity@@of@@TAXOL@@may@@be@@exacerbated@@in@@patients@@with@@serum@@total@@bilirubin@@@@2@@times@@ULN@@.@@"> 
      <entity id="DDI-DrugBank.d288.s23.e0" charOffset="61-65" type="brand" text="TAXOL" position="10"/> 
   </sentence>  
   <sentence id="DDI-DrugBank.d288.s24" text="Extreme caution should be exercised when administering TAXOL to such patients, with dose reduction as recommended in DOSAGE AND ADMINISTRATION, Table 17." new_text="Extreme@@caution@@should@@be@@exercised@@when@@administering@@TAXOL@@to@@such@@patients@@,@@with@@dose@@reduction@@as@@recommended@@in@@DOSAGE@@AND@@ADMINISTRATION@@,@@Table@@17@@.@@"> 
      <entity id="DDI-DrugBank.d288.s24.e0" charOffset="55-59" type="brand" text="TAXOL" position="7"/> 
   </sentence>  
   <sentence id="DDI-DrugBank.d288.s25" text="InjectionSite Reaction: Injection site reactions, including reactions secondary to extravasation, were usually mild and consisted of erythema, tenderness, skin discoloration, or swelling at the injection site." new_text="InjectionSite@@Reaction@@:@@Injection@@site@@reactions@@,@@including@@reactions@@secondary@@to@@extravasation@@,@@were@@usually@@mild@@and@@consisted@@of@@erythema@@,@@tenderness@@,@@skin@@discoloration@@,@@or@@swelling@@at@@the@@injection@@site@@.@@"/>  
   <sentence id="DDI-DrugBank.d288.s26" text="These reactions have been observed more frequently with the 24-hour infusion than with the 3-hour infusion." new_text="These@@reactions@@have@@been@@observed@@more@@frequently@@with@@the@@24-hour@@infusion@@than@@with@@the@@3-hour@@infusion@@.@@"/>  
   <sentence id="DDI-DrugBank.d288.s27" text="Recurrence of skin reactions at a site of previous extravasation following administration of TAXOL at a different site, ie, recall, has been reported rarely." new_text="Recurrence@@of@@skin@@reactions@@at@@a@@site@@of@@previous@@extravasation@@following@@administration@@of@@TAXOL@@at@@a@@different@@site@@,@@ie@@,@@recall@@,@@has@@been@@reported@@rarely@@.@@"> 
      <entity id="DDI-DrugBank.d288.s27.e0" charOffset="93-97" type="brand" text="TAXOL" position="13"/> 
   </sentence>  
   <sentence id="DDI-DrugBank.d288.s28" text="Rare reports of more severe events such as phlebitis, cellulitis, induration, skin exfoliation, necrosis, and fibrosis have been received as part of the continuing surveillance of TAXOL safety." new_text="Rare@@reports@@of@@more@@severe@@events@@such@@as@@phlebitis@@,@@cellulitis@@,@@induration@@,@@skin@@exfoliation@@,@@necrosis@@,@@and@@fibrosis@@have@@been@@received@@as@@part@@of@@the@@continuing@@surveillance@@of@@TAXOL@@safety@@.@@"> 
      <entity id="DDI-DrugBank.d288.s28.e0" charOffset="180-184" type="brand" text="TAXOL" position="31"/> 
   </sentence>  
   <sentence id="DDI-DrugBank.d288.s29" text="In some cases the onset of the injection site reaction either occurred during a prolonged infusion or was delayed by a week to ten days." new_text="In@@some@@cases@@the@@onset@@of@@the@@injection@@site@@reaction@@either@@occurred@@during@@a@@prolonged@@infusion@@or@@was@@delayed@@by@@a@@week@@to@@ten@@days@@.@@"/>  
   <sentence id="DDI-DrugBank.d288.s30" text="A specific treatment for extravasation reactions is unknown at this time." new_text="A@@specific@@treatment@@for@@extravasation@@reactions@@is@@unknown@@at@@this@@time@@.@@"/>  
   <sentence id="DDI-DrugBank.d288.s31" text="Given the possibility of extravasation, it is advisable to closely monitor the infusion site for possible infiltration during drug administration." new_text="Given@@the@@possibility@@of@@extravasation@@,@@it@@is@@advisable@@to@@closely@@monitor@@the@@infusion@@site@@for@@possible@@infiltration@@during@@drug@@administration@@.@@"/> 
</document>
